Modifications such as H3K27me3 (mediated by enhancer of zeste homolog 2 [EZH2]/KMT6) repress gene expression and enhance Wnt/β‐catenin signaling, driving HCC aggressiveness.88 This evidence concerns the gene EZH2 and hepatocellular carcinoma.